3 Fast-Growing Stocks to Buy Now

01:00pm, Sunday, 31'st Jul 2022 The Motley Fool
ShockWave, Vir, and BioCryst are all seeing skyrocketing sales this quarter.

2 Biotech Stocks That Could Help Make You a Fortune

10:15am, Saturday, 30'th Jul 2022 The Motley Fool
These companies have seen triple-digit revenue growth in recent years.
GSK PLC ( GSK , Financial) completed the long-awaited spinoff of its consumer health care business Haleon ( HLN , Financial) on July 18. Shareholders received one Haleon share for each GSK share owned
Early Wednesday, GSK stock dipped slightly despite beating second-quarter expectations and raising its full-year guidance. The post Drug Behemoth GSK Delivers Strong Beat And Raise, But Shares Fell ap

GSK Raises Full-Year Forecast

04:49am, Wednesday, 27'th Jul 2022
The pharmaceutical company says it expects adjusted operating profit for the year to rise 13% to 15%, higher than previous guidance of 12% to 14%.
GSK PLC (LSE:GSK, NYSE:GSK) has raised its full-year guidance after a bumper second quarter that exceeded City expectations. The drugs giant now expects 2022 sales to increase by 6% to 8%, compared wi
GSK on Wednesday lifted its full-year forecast, boosted by reinvigorated demand for its blockbuster Shingrix vaccine, days after overhauling the business with the spinoff of its consumer health unit.
Let's look what is in store for the four drug, biotech companies slated to release quarterly results tomorrow- BMY, GSK, ALKS, TEVA
Amid the next huge batch of corporate updates, attention Wednesday will turn towards the conclusion of the Federal Reserve's latest interest rate-setting meeting.  When  US inflation recently jumpe
GSK PLC (LSE:GSK, NYSE:GSK)'s second-quarter figures will provide the first clues as to whether the business will flourish or founder following the £30bn demerger of its consumer business, Haleon. Re

GSK Completes Demerger of Consumer Healthcare Business

02:24pm, Tuesday, 19'th Jul 2022 Zacks Investment Research
Post demerger, GSK is set to focus on its Pharmaceuticals and Vaccines businesses. The consumer healthcare business, Haleon, will start regular-way trading on the NYSE from Jul 22.

The Zacks Analyst Blog Highlights Apple, UnitedHealth Group, Equinor, GSK and Eaton

10:05am, Tuesday, 19'th Jul 2022 Zacks Investment Research
Apple, UnitedHealth Group, Equinor, GSK and Eaton have been included in this Analyst Blog.
After GSK (NYSE: GSK) spun off its consumer health division Haleon Plc (LSE: HLN) into a separate entity, shares of the newly listed firm plunged during intraday trade, closing over 6.5% down at GBX 

Top Analyst Reports for Apple, UnitedHealth, Equinor & Others

08:04pm, Monday, 18'th Jul 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), UnitedHealth Group Incorporated (UNH), and Equinor ASA (EQNR).

GlaxoSmithKline (GSK) Dips More Than Broader Markets: What You Should Know

10:00pm, Thursday, 14'th Jul 2022 Zacks Investment Research
GlaxoSmithKline (GSK) closed at $40.22 in the latest trading session, marking a -1.71% move from the prior day.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE